The Acute Effects of Cocoa Flavanols Intake on Overt and Covert Attention

NCT ID: NCT06812689

Last Updated: 2025-02-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-26

Study Completion Date

2023-01-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present study aimed to examine whether a cocoa beverage containing 710 mg of flavanols enhances both overt and covert attention in healthy young adults, using a randomized, double-blind, baseline- and placebo-controlled crossover design.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cocoa flavanols (CF) have various physiological effects that may directly or indirectly enhance cognitive functions. Following CF intake, a series of biochemical processes within vascular smooth muscle cells lead to the relaxation of smooth muscles, the dilation of blood vessels, and an increase in cerebral blood flow. For the brain to function optimally, cerebral blood flow must be maintained at a level that ensures a constant supply of oxygen and glucose to neurons. During periods of intense neuronal activity, neurons require more oxygen and nutrients, which is met by an increase in blood flow. Given that CF has been shown to enhance blood flow and perfusion in brain regions associated with attention (e.g., the parietal cortex, anterior cingulate cortex, and dorsolateral prefrontal cortex), it was hypothesized that CF intake could acutely improve both overt and covert attention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Young Adults

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Baseline/Placebo/Flavanol

Participants consumed sugar water, an alkalized cocoa beverage, and a natural cocoa beverage containing 710 mg of flavanols, with a one-week washout period between interventions.

Group Type EXPERIMENTAL

Flavanol

Intervention Type DIETARY_SUPPLEMENT

Natural cocoa powder containing 710 mg of flavanols was dissolved in 250 mL of hot water and sweetened with 6 g of sugar.

Placebo

Intervention Type DIETARY_SUPPLEMENT

Alkalized cocoa powder containing no flavanols was dissolved in 250 mL of hot water and sweetened with 6 g of sugar.

Sugar water

Intervention Type OTHER

250 mL of hot water with 6 g of sugar

Baseline/Flavanol/Placebo

Participants consumed sugar water, a natural cocoa beverage containing 710 mg of flavanols, and an alkalized cocoa beverage, with a one-week washout period between interventions.

Group Type EXPERIMENTAL

Flavanol

Intervention Type DIETARY_SUPPLEMENT

Natural cocoa powder containing 710 mg of flavanols was dissolved in 250 mL of hot water and sweetened with 6 g of sugar.

Placebo

Intervention Type DIETARY_SUPPLEMENT

Alkalized cocoa powder containing no flavanols was dissolved in 250 mL of hot water and sweetened with 6 g of sugar.

Sugar water

Intervention Type OTHER

250 mL of hot water with 6 g of sugar

Placebo/Baseline/Flavanol

Participants consumed an alkalized cocoa beverage, sugar water, and a natural cocoa beverage containing 710 mg of flavanols, with a one-week washout period between interventions.

Group Type EXPERIMENTAL

Flavanol

Intervention Type DIETARY_SUPPLEMENT

Natural cocoa powder containing 710 mg of flavanols was dissolved in 250 mL of hot water and sweetened with 6 g of sugar.

Placebo

Intervention Type DIETARY_SUPPLEMENT

Alkalized cocoa powder containing no flavanols was dissolved in 250 mL of hot water and sweetened with 6 g of sugar.

Sugar water

Intervention Type OTHER

250 mL of hot water with 6 g of sugar

Placebo/Flavanol/Baseline

Participants consumed an alkalized cocoa beverage, a natural cocoa beverage containing 710 mg of flavanols, and sugar water, with a one-week washout period between interventions.

Group Type EXPERIMENTAL

Flavanol

Intervention Type DIETARY_SUPPLEMENT

Natural cocoa powder containing 710 mg of flavanols was dissolved in 250 mL of hot water and sweetened with 6 g of sugar.

Placebo

Intervention Type DIETARY_SUPPLEMENT

Alkalized cocoa powder containing no flavanols was dissolved in 250 mL of hot water and sweetened with 6 g of sugar.

Sugar water

Intervention Type OTHER

250 mL of hot water with 6 g of sugar

Flavanol/Baseline/Placebo

Participants consumed a natural cocoa beverage containing 710 mg of flavanols, sugar water, and an alkalized cocoa beverage, with a one-week washout period between interventions.

Group Type EXPERIMENTAL

Flavanol

Intervention Type DIETARY_SUPPLEMENT

Natural cocoa powder containing 710 mg of flavanols was dissolved in 250 mL of hot water and sweetened with 6 g of sugar.

Placebo

Intervention Type DIETARY_SUPPLEMENT

Alkalized cocoa powder containing no flavanols was dissolved in 250 mL of hot water and sweetened with 6 g of sugar.

Sugar water

Intervention Type OTHER

250 mL of hot water with 6 g of sugar

Flavanol/Placebo/Baseline

Participants consumed a natural cocoa beverage containing 710 mg of flavanols, an alkalized cocoa beverage, and sugar water, with a one-week washout period between interventions.

Group Type EXPERIMENTAL

Flavanol

Intervention Type DIETARY_SUPPLEMENT

Natural cocoa powder containing 710 mg of flavanols was dissolved in 250 mL of hot water and sweetened with 6 g of sugar.

Placebo

Intervention Type DIETARY_SUPPLEMENT

Alkalized cocoa powder containing no flavanols was dissolved in 250 mL of hot water and sweetened with 6 g of sugar.

Sugar water

Intervention Type OTHER

250 mL of hot water with 6 g of sugar

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Flavanol

Natural cocoa powder containing 710 mg of flavanols was dissolved in 250 mL of hot water and sweetened with 6 g of sugar.

Intervention Type DIETARY_SUPPLEMENT

Placebo

Alkalized cocoa powder containing no flavanols was dissolved in 250 mL of hot water and sweetened with 6 g of sugar.

Intervention Type DIETARY_SUPPLEMENT

Sugar water

250 mL of hot water with 6 g of sugar

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Normal or corrected-to-normal visual acuity

Exclusion Criteria

* History of neurological, psychiatric, cardiovascular or metabolic disorders
* Following a medically restricted diet
* Taking antidepressant, anxiolytic, and antipsychotic drugs in the past three months
* Currently taking anticoagulant
* Taking herbal supplements in the past week
* Allergic or intolerant to cocoa, caffeine, sucrose, or fructose
* Color blindness
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Scientific and Technological Research Council of Turkey

OTHER

Sponsor Role collaborator

Konya Necmettin Erbakan Üniversitesi

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Oğuz Karataş

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Oğuz Karataş, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Konya Necmettin Erbakan University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Konya Necmettin Erbakan University Cognitive Psychology Laboratuary

Konya, Konya, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Karataş O, Karabay A, Alıcı T. Uzun süreli kakao flavanolleri alımının bilişsel işlevlere ve duygudurumuna etkileri ve bu etkilerin altındaki fizyolojik mekanizmalar: Bir derleme çalışması. Türk Psikoloji Yazıları. 2022;25(49):1-26. http://dx.doi.org/10.31828/tpy1301996120211203m000043

Reference Type BACKGROUND

Lamport DJ, Pal D, Moutsiana C, Field DT, Williams CM, Spencer JP, Butler LT. The effect of flavanol-rich cocoa on cerebral perfusion in healthy older adults during conscious resting state: a placebo controlled, crossover, acute trial. Psychopharmacology (Berl). 2015 Sep;232(17):3227-34. doi: 10.1007/s00213-015-3972-4. Epub 2015 Jun 7.

Reference Type BACKGROUND
PMID: 26047963 (View on PubMed)

Francis ST, Head K, Morris PG, Macdonald IA. The effect of flavanol-rich cocoa on the fMRI response to a cognitive task in healthy young people. J Cardiovasc Pharmacol. 2006;47 Suppl 2:S215-20. doi: 10.1097/00005344-200606001-00018.

Reference Type BACKGROUND
PMID: 16794461 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

122K636

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.